Neurobiology of Aging
Volume 24, Issue 1 , Pages 191-193 , January 2003

Biological markers in Alzheimer disease

Received 25 March 2002 ,Accepted 27 March 2002.

References 

  1. Cherny R, Atwood C, Xilinas M, Gray D, Jones W, McLean C, et al.  Treatment with a copper–zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer’s disease transgenic mice. Neuron. 2001;30:665–676
  2. Del Bo R, Comi GP, Perini MP, Strazzer S, Bresolin N, Scarlato G. Down’s syndrome fibroblasts anticipate the accumulation of specific aging-related mtDNA mutations. Ann. Neurol. 2001;49:137–168
  3. De Luigi A, Fragiacomo C, Lucca U, Quadri P, Tettamanti M, De Simoni MG. Inflammatory markers in Alzheimer’s disease and multi-infarct dementia. Mech. Aging Dev. 2001;122/16:1985–1995
  4. Facheris M, Galbusera C, Magni F, Begni B, Galimberti G, Zoia C, et al. Increased lipid peroxidation in plasma from Alzheimer disease and mild cognitive impairment patients. Abstract book V Scientific Meeting ITINAD Roma, 2001. p. 64.
  5. Ferrarese C, Zoia C, Pecora N, Piolti R, Frigo M, Bianchi G, et al.  Reduced platelet glutamate uptake in Parkinson’s disease. J. Neural Transm. 1999;106:685–692
  6. Ferrarese C, Begni B, Canevari C, Zoia C, Piolti R, Frigo M, et al.  Glutamate uptake is decreased in platelets from Alzheimer patients. Ann. Neurol. 2000;47:641–643
  7. Ferrarese C, Sala G, Riva R, Begni B, Zoia C, Tremolizzo L, et al.  Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology. 2001;56:270–272
  8. Galimberti G, Sala G, Canevari C, Agazzi C, Raggi ME, Ferrarese C. Cytokine release from peripheral blood cells of Alzheimer (AD) and mild cognitive impairment (MCI) patients. Abstract book V Scientific Meeting ITINAD Roma, 2001. p. 67.
  9. Galli Kienle M, Ferrarese C, Begni B, Zoia C, Brighina L, Cattaneo A, et al. Adducts of Aβ peptides with hydroxynonenal as possible early markers of Alzheimer’s disease. In: Proceedings of the 42nd International Conference on the Bioscience of Lipids, Bergen, Norvegia. Chem. Phys. Lipids 2001;110:144.
  10. Licastro F, Pedrini S, Caputo L, Annoni G, Davis LJ, Ferri C, et al.  Increased plasma levels of interleukin-1, interleukin-6 and a-1-antichymotrypsin in patients with Alzheimer’s disease: peripheral inflammation or signals from the brain?. J. Neuroimmunol. 2000;103:97–102
  11. Padovani A, Pastorino L, Borroni B, Colciaghi F, Rozzini L, Monastero R, et al.  Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology. 2001;57:2243–2248
  12. Padovani A, Borroni B, Colciaghi F, Pettenati C, Cottini E, Agosti C, et al.  Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch. Neurol. 2002;59:71–75
  13. Pitto M, Ravasi D, Raimondo F, Guzzi F, Masserini M. Studies on the caveolar localization of amyloid precursor protein in human cultured fibroblasts. J. Neurochem. 2001;77(1):24

☆ Report of the International Symposium, sponsored by the Italian Interdisciplinary Network on Alzheimer Disease (ITINAD), University of Milano-Bicocca-Monza (Italy), November 3, 2001.

PII: S0197-4580(02)00051-9

Neurobiology of Aging
Volume 24, Issue 1 , Pages 191-193 , January 2003

Article Tools